| Miss Jodi-ann Nicole Foster, PT, DPT | |
|
17900 Nw 5th St Ste 103, Pembroke Pines, FL 33029-2809 | |
| (954) 435-9905 | |
| Not Available |
| Full Name | Miss Jodi-ann Nicole Foster |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 15 Years |
| Location | 17900 Nw 5th St Ste 103, Pembroke Pines, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023332491 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | PT24947 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthcare Partners Affiliates Medical Group | 7315842002 | 658 |
News Archive
The American Association of Critical-Care Nurses (AACN) will bestow the 2015 Circle of Excellence Award on 25 nurses nationwide at the National Teaching Institute & Critical Care Exposition (NTI), San Diego, May 18-21.
A gene therapy approach to treating the progressive muscle wasting disorder Duchenne muscular dystrophy (DMD) that does not replace the mutated DMD gene but instead delivers the gene for ITGA7, a protein in skeletal muscle, led to reduced symptoms and significantly extended life span in a mouse model of severe DMD. Over-expression of ITGA7 did not elicit an immune reaction, further supporting its potential as a novel treatment for DMD, according to a new study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Researchers at St. Michael's Hospital in Toronto are part of an international team of researchers recently awarded a multi-million dollar grant for their work in cardiovascular disease among Indigenous people in Canada, Australia and New Zealand. The Canadian team will receive $742,000 in funding for its part of the project from the Canadian Institutes of Health Research and International Collaborative Indigenous Health Research Partnerships.
Two clinical trials led by Johns Hopkins Kimmel Cancer Center researchers in collaboration with other medical centers, testing experimental drugs aimed at restoring the immune system's ability to spot and attack cancer, have shown promising early results in patients with advanced non-small cell lung cancer, melanoma, and kidney cancer.
Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein - but no one has known how that alteration promotes cancer growth. Now, Weill Cornell Medical College researchers have found that in these cancer cells, the 3-D architecture of DNA, wrapped up in a little ball known as a chromatin, is warped in such a way that a switch has been thrown on thousands of genes, turning them on or off to promote abnormal, unchecked growth. Researchers also found that new chromosomal translocations form, further destabilizing the genome.
› Verified 8 days ago
| Provider Name | Healthcare Partners Affiliates Medical Group |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1659312593 PECOS PAC ID: 7315842002 Enrollment ID: O20031204001258 |
News Archive
The American Association of Critical-Care Nurses (AACN) will bestow the 2015 Circle of Excellence Award on 25 nurses nationwide at the National Teaching Institute & Critical Care Exposition (NTI), San Diego, May 18-21.
A gene therapy approach to treating the progressive muscle wasting disorder Duchenne muscular dystrophy (DMD) that does not replace the mutated DMD gene but instead delivers the gene for ITGA7, a protein in skeletal muscle, led to reduced symptoms and significantly extended life span in a mouse model of severe DMD. Over-expression of ITGA7 did not elicit an immune reaction, further supporting its potential as a novel treatment for DMD, according to a new study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Researchers at St. Michael's Hospital in Toronto are part of an international team of researchers recently awarded a multi-million dollar grant for their work in cardiovascular disease among Indigenous people in Canada, Australia and New Zealand. The Canadian team will receive $742,000 in funding for its part of the project from the Canadian Institutes of Health Research and International Collaborative Indigenous Health Research Partnerships.
Two clinical trials led by Johns Hopkins Kimmel Cancer Center researchers in collaboration with other medical centers, testing experimental drugs aimed at restoring the immune system's ability to spot and attack cancer, have shown promising early results in patients with advanced non-small cell lung cancer, melanoma, and kidney cancer.
Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein - but no one has known how that alteration promotes cancer growth. Now, Weill Cornell Medical College researchers have found that in these cancer cells, the 3-D architecture of DNA, wrapped up in a little ball known as a chromatin, is warped in such a way that a switch has been thrown on thousands of genes, turning them on or off to promote abnormal, unchecked growth. Researchers also found that new chromosomal translocations form, further destabilizing the genome.
› Verified 8 days ago
| Provider Name | Pure Wellness Inc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1558022004 PECOS PAC ID: 9537552369 Enrollment ID: O20220131001265 |
News Archive
The American Association of Critical-Care Nurses (AACN) will bestow the 2015 Circle of Excellence Award on 25 nurses nationwide at the National Teaching Institute & Critical Care Exposition (NTI), San Diego, May 18-21.
A gene therapy approach to treating the progressive muscle wasting disorder Duchenne muscular dystrophy (DMD) that does not replace the mutated DMD gene but instead delivers the gene for ITGA7, a protein in skeletal muscle, led to reduced symptoms and significantly extended life span in a mouse model of severe DMD. Over-expression of ITGA7 did not elicit an immune reaction, further supporting its potential as a novel treatment for DMD, according to a new study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Researchers at St. Michael's Hospital in Toronto are part of an international team of researchers recently awarded a multi-million dollar grant for their work in cardiovascular disease among Indigenous people in Canada, Australia and New Zealand. The Canadian team will receive $742,000 in funding for its part of the project from the Canadian Institutes of Health Research and International Collaborative Indigenous Health Research Partnerships.
Two clinical trials led by Johns Hopkins Kimmel Cancer Center researchers in collaboration with other medical centers, testing experimental drugs aimed at restoring the immune system's ability to spot and attack cancer, have shown promising early results in patients with advanced non-small cell lung cancer, melanoma, and kidney cancer.
Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein - but no one has known how that alteration promotes cancer growth. Now, Weill Cornell Medical College researchers have found that in these cancer cells, the 3-D architecture of DNA, wrapped up in a little ball known as a chromatin, is warped in such a way that a switch has been thrown on thousands of genes, turning them on or off to promote abnormal, unchecked growth. Researchers also found that new chromosomal translocations form, further destabilizing the genome.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Miss Jodi-ann Nicole Foster, PT, DPT 16520 Nw 11th Ct, Pembroke Pines, FL 33028-1306 Ph: () - | Miss Jodi-ann Nicole Foster, PT, DPT 17900 Nw 5th St Ste 103, Pembroke Pines, FL 33029-2809 Ph: (954) 435-9905 |
News Archive
The American Association of Critical-Care Nurses (AACN) will bestow the 2015 Circle of Excellence Award on 25 nurses nationwide at the National Teaching Institute & Critical Care Exposition (NTI), San Diego, May 18-21.
A gene therapy approach to treating the progressive muscle wasting disorder Duchenne muscular dystrophy (DMD) that does not replace the mutated DMD gene but instead delivers the gene for ITGA7, a protein in skeletal muscle, led to reduced symptoms and significantly extended life span in a mouse model of severe DMD. Over-expression of ITGA7 did not elicit an immune reaction, further supporting its potential as a novel treatment for DMD, according to a new study published in Human Gene Therapy, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers.
Researchers at St. Michael's Hospital in Toronto are part of an international team of researchers recently awarded a multi-million dollar grant for their work in cardiovascular disease among Indigenous people in Canada, Australia and New Zealand. The Canadian team will receive $742,000 in funding for its part of the project from the Canadian Institutes of Health Research and International Collaborative Indigenous Health Research Partnerships.
Two clinical trials led by Johns Hopkins Kimmel Cancer Center researchers in collaboration with other medical centers, testing experimental drugs aimed at restoring the immune system's ability to spot and attack cancer, have shown promising early results in patients with advanced non-small cell lung cancer, melanoma, and kidney cancer.
Up to half of all prostate cancer cells have a chromosomal rearrangement that results in a new "fusion" gene and formation of its unique protein - but no one has known how that alteration promotes cancer growth. Now, Weill Cornell Medical College researchers have found that in these cancer cells, the 3-D architecture of DNA, wrapped up in a little ball known as a chromatin, is warped in such a way that a switch has been thrown on thousands of genes, turning them on or off to promote abnormal, unchecked growth. Researchers also found that new chromosomal translocations form, further destabilizing the genome.
› Verified 8 days ago
Amanda Cardenas, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 17796 Sw 2nd St, Pembroke Pines, FL 33029 Phone: 954-438-7800 | |
Monica Odalmis Gonzalez, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 16192 Nw 14th Ct, Pembroke Pines, FL 33028 Phone: 954-260-6428 | |
Zanaba Goins, DR Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 17796 Sw 2nd St, Pembroke Pines, FL 33029 Phone: 954-438-7800 | |
Ms. Joan Hudson, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 17900 Nw 5th St, Suite 103, Pembroke Pines, FL 33029 Phone: 954-435-9905 Fax: 954-435-3769 | |
Mrs. Lina Maria Peterson, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 10794 Pines Blvd, Pembroke Pines, FL 33026 Phone: 954-447-0296 Fax: 954-447-3131 | |
Mr. Roberto Mcgrath, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 17796 Sw 2nd St, Pembroke Pines, FL 33029 Phone: 954-438-7800 | |
Justine Fradillada, Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 10261 Pines Blvd, Pembroke Pines, FL 33026 Phone: 954-356-2878 |